A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Irinotecan (Primary) ; MABp1 (Primary) ; Fluorouracil; Folinic acid
- Indications Cachexia; Pancreatic cancer
- Focus Adverse reactions
- 18 Oct 2017 According to an XBiotech media release, the first patient has been enrolled in this trial.
- 18 Oct 2017 According to an XBiotech media release, status changed from not yet recruiting to recruiting.
- 07 Jul 2017 New trial record